Log in

Recro Pharma SEC Filings & 10K Form (NASDAQ:REPH)

$12.18
+0.06 (+0.50 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
$12.03
Now: $12.18
$12.30
50-Day Range
$10.82
MA: $11.62
$12.21
52-Week Range
$5.53
Now: $12.18
$12.67
Volume83,670 shs
Average Volume171,729 shs
Market Capitalization$273.20 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.5

SEC Filings

Recro Pharma (NASDAQ:REPH) SEC Filings

DateFilerForm TypeView
08/08/2019
6:58 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2019
4:19 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:58 PM
BlackRock Inc. (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
05/21/2019
3:11 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
7:52 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:30 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:06 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
9:43 AM
Flynn Karen (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:27 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:26 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:25 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:25 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:24 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
1:50 PM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
5:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
3:01 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
11:46 AM
Recro Pharma (Filer)
Form DEFA14A
03/28/2019
5:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2019
4:44 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:42 PM
Ajdler Arnaud (Reporting)
Recro Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2019
3:17 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
11:16 PM
Recro Pharma (Filer)
Form EFFECT
03/20/2019
7:00 PM
Recro Pharma (Filer)
Form DEFA14A
03/20/2019
6:57 PM
Recro Pharma (Filer)
Form DEF 14A
03/18/2019
1:44 PM
Recro Pharma (Filer)
Form CT ORDER
03/07/2019
12:22 PM
Recro Pharma (Filer)
Form CT ORDER
03/06/2019
4:02 PM
Recro Pharma (Filer)
Form 8-K/A
03/04/2019
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
3:12 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4/A
02/19/2019
3:12 PM
Celano Michael (Reporting)
Recro Pharma (Issuer)
Form 4/A
02/19/2019
3:11 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4/A
02/19/2019
9:07 AM
Recro Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/19/2019
7:39 AM
Recro Pharma (Filer)
Form 424B5
02/19/2019
6:23 AM
Recro Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2019
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:28 PM
Alyeska Investment Group, L.P. (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
02/12/2019
3:15 PM
Flynn James E (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
01/23/2019
3:08 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:06 PM
Celano Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:05 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:01 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
5:28 PM
Celano Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:39 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:37 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:40 PM
HENWOOD GERALDINE (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
1:39 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
1:07 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
6:06 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/09/2018
5:07 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2018
11:00 PM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
6:00 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
6:07 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2018
3:33 PM
Lake Ryan David (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
4:10 PM
Broadfin Capital, LLC (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
05/24/2018
4:02 PM
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
6:05 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:54 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:53 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:51 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:50 PM
ALTOMARI ALFRED (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:48 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
6:01 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
6:00 PM
Ashton William (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
5:59 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
5:58 PM
ALTOMARI ALFRED (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
5:57 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
5:56 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4/A
05/10/2018
5:54 PM
Flynn Karen (Reporting)
Recro Pharma (Issuer)
Form 4/A
05/10/2018
6:03 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
6:01 AM
Recro Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
6:01 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
4:29 PM
Ashton William (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:28 PM
Reasons Bryan M. (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:27 PM
ALTOMARI ALFRED (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:26 PM
CHURCHILL WINSTON J (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:25 PM
Flynn Karen (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:24 PM
Recro Pharma (Issuer)
Weisman Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:21 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2018
8:41 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
6:15 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2018
3:35 PM
Recro Pharma (Filer)
Form DEFA14A
03/23/2018
3:32 PM
Recro Pharma (Filer)
Form DEF 14A
03/21/2018
3:05 PM
Recro Pharma (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
03/15/2018
3:19 PM
Broadfin Capital, LLC (Filed by)
Recro Pharma (Subject)
Form SC 13D/A
03/15/2018
3:11 PM
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
3:15 PM
Berelowitz Michael (Reporting)
Recro Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2018
6:31 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
2:50 PM
BlackRock Inc. (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
03/02/2018
4:25 PM
Recro Pharma (Filer)
Form 424B5
02/28/2018
6:31 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2018
6:30 AM
Recro Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
1:36 PM
Alyeska Investment Group, L.P. (Filed by)
Recro Pharma (Subject)
Form SC 13G
02/14/2018
8:40 AM
LYTTON LAURENCE W (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
02/14/2018
7:42 AM
Flynn James E (Filed by)
Recro Pharma (Subject)
Form SC 13G/A
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel